These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 6463588)

  • 21. Role of high-molecular-weight kininogen in surface-binding and activation of coagulation Factor XI and prekallikrein.
    Wiggins RC; Bouma BN; Cochrane CG; Griffin JH
    Proc Natl Acad Sci U S A; 1977 Oct; 74(10):4636-40. PubMed ID: 270705
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein.
    Meier HL; Pierce JV; Colman RW; Kaplan AP
    J Clin Invest; 1977 Jul; 60(1):18-31. PubMed ID: 874082
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The "contact system" in health and disease.
    Saito H
    Adv Intern Med; 1980; 25():217-38. PubMed ID: 6987842
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Additional factor XII (Hageman factor) deficiency in hemophilia A and in von Willebrand syndrome.
    Barthels M; Edel J; Liese B; Karges HE
    Klin Wochenschr; 1982 Mar; 60(6):303-9. PubMed ID: 6978968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interactions among Hageman factor, plasma prekallikrein, high molecular weight kininogen, and plasma thromboplastin antecedent.
    Ratnoff OD; Saito H
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):958-61. PubMed ID: 284420
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Factor XII deficiency in a man with gout and angioimmunoblastic lymphadenopathy.
    Londino AV; Luparello FJ
    Arch Intern Med; 1984 Jul; 144(7):1497-8. PubMed ID: 6732412
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of Hageman factor, prekallifrein, and high molecular weight kininogen in the generation of bradykinin and the initiation of coagulation and fibrinolysis.
    Kaplan AP; Meier HL; Mandle RJ
    Monogr Allergy; 1977; 12():120-30. PubMed ID: 335210
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical implications of factor XII deficiency.
    McDonough RJ; Nelson CL
    Oral Surg Oral Med Oral Pathol; 1989 Sep; 68(3):264-6. PubMed ID: 2771371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ischemic stroke in a patient with factor XII (Hageman) deficiency.
    Foncea N; Gómez Beldarrain M; Ruiz Ojeda J; Carrascosa T; García-Moncó J
    Neurologia; 2001 May; 16(5):227-8. PubMed ID: 11412723
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Studies on the blood clotting and fibrinolytic system in the plasma from a sei (baleen) whale.
    Saito H; Poon M; Goldsmith GH; Ratnoff OD; Arnason U
    Proc Soc Exp Biol Med; 1976 Sep; 152(4):503-7. PubMed ID: 967876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Concomitant ST-elevation myocardial infarction and deep vein thrombosis in a patient with severe factor XII deficiency: case report and review of the literature.
    Cei M; Mumoli N; Giuntoli S; Marino O; Pasquinelli P; Taddei P; Mandolesi C; Genovesi Ebert A
    QJM; 2011 Dec; 104(12):1083-6. PubMed ID: 21106502
    [No Abstract]   [Full Text] [Related]  

  • 32. The role of high molecular weight kininogen in contact activation of coagulation, fibrinolysis and kinin generation.
    Kaplan AP
    Adv Exp Med Biol; 1979; 120B():71-91. PubMed ID: 390992
    [No Abstract]   [Full Text] [Related]  

  • 33. The role of prekallikrein and high-molecular-weight kininogen in the contact activation of Hageman factor (factor XII) by sulfatides and other agents.
    España F; Ratnoff OD
    J Lab Clin Med; 1983 Oct; 102(4):487-99. PubMed ID: 6604770
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Factor XII (Hageman factor) deficiency: a risk factor for development of thromboembolism. Incidence of factor XII deficiency in patients after recurrent venous or arterial thromboembolism and myocardial infarction].
    Halbmayer WM; Mannhalter C; Feichtinger C; Rubi K; Fischer M
    Wien Med Wochenschr; 1993; 143(2):43-50. PubMed ID: 8488686
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Adult nephrotic syndrome and acquired coagulopathies: Hageman factor deficiency.
    Branson HE; Vaziri ND; Slater LM
    J Natl Med Assoc; 1982 Apr; 74(4):339-43. PubMed ID: 7120469
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperprolactinemia and reduction in plasma titers of Hageman factor, prekallikrein, and high molecular weight kininogen in patients with acute myocardial infarction.
    La Follette L; Gordon EM; Mazur CA; Ratnoff OD; Yamashita TS
    J Lab Clin Med; 1987 Sep; 110(3):318-21. PubMed ID: 3649393
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Plasmin-mediated activation of contact system in response to pharmacological thrombolysis.
    Ewald GA; Eisenberg PR
    Circulation; 1995 Jan; 91(1):28-36. PubMed ID: 7805216
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The role of HF cofactor in the Hageman factor-dependent fibrinolytic mechanism.
    Iatridis PG; Gadarowski JJ; Iatridis SG
    Acta Haematol; 1981; 66(4):257-63. PubMed ID: 6800192
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Rabbit blood coagulation factor XI. Mechanism of activation of rabbit Hageman factor (factor XII).
    Wiggins RC; Cochrane CG; Griffin JH
    Thromb Res; 1979; 15(3-4):487-95. PubMed ID: 494157
    [No Abstract]   [Full Text] [Related]  

  • 40. [Moderate deficiency of Factor XII associated with postoperative deep venous thrombosis].
    Cornudella R; Puente F; Hortells JL; Gutiérrez M
    Sangre (Barc); 1989 Apr; 34(2):144-6. PubMed ID: 2756451
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.